“The revision to stable reflects MaineHealth’s better-than-anticipated financial performance in 2014 and 2015 coupled with its strong enterprise profile,” said S&P credit analyst Cynthia Keller. “We expect MaineHealth’s increasingly centralized operations and local consolidation efforts will stabilize, and perhaps improve, future financial performance.”
S&P also affirmed the “A+” rating on MaineHealth’s series 2014 revenue bonds, affecting $85 million.
More articles on healthcare finance:
7 recent hospital outlook and credit rating actions
Price tag for UC San Diego specialty hospital approaches $1B
CMS finalizes ACA rule on Medicaid prescription drug rebates, reimbursements
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
